A Look At Roche Holding's Business & Outlook

Roche Holding (NASDAQ:RHHBY) generates its revenues from its Oncology, Autoimmune, Virology, Opthalmology, Neuroscience, Metabolism & Other drugs, along with its In-Vitro Diagnostics business. Oncology accounts for roughly half of the company's total revenues. However, most of its blockbuster...